Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
22316 | 329 | 33.0 | 73% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PIT CELLS | Author keyword | 5 | 47% | 2% | 8 |
2 | ACTIVATED NATURAL KILLER CELLS | Author keyword | 4 | 67% | 1% | 4 |
3 | A NK CELLS | Author keyword | 4 | 75% | 1% | 3 |
4 | A NK CELL | Author keyword | 2 | 67% | 1% | 2 |
5 | COMBINED IMMUNOCHEMOTHERAPY | Author keyword | 2 | 67% | 1% | 2 |
6 | LOCOREGIONAL IMMUNO CHEMOTHERAPY | Author keyword | 2 | 67% | 1% | 2 |
7 | LIVER ASSOCIATED LYMPHOCYTES | Author keyword | 1 | 38% | 1% | 3 |
8 | SECONDARY LIVER TUMORS | Author keyword | 1 | 50% | 1% | 2 |
9 | T LAK CELLS | Author keyword | 1 | 100% | 1% | 2 |
10 | TISSUE ISOLATED TUMORS | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PIT CELLS | 5 | 47% | 2% | 8 | Search PIT+CELLS | Search PIT+CELLS |
2 | ACTIVATED NATURAL KILLER CELLS | 4 | 67% | 1% | 4 | Search ACTIVATED+NATURAL+KILLER+CELLS | Search ACTIVATED+NATURAL+KILLER+CELLS |
3 | A NK CELLS | 4 | 75% | 1% | 3 | Search A+NK+CELLS | Search A+NK+CELLS |
4 | A NK CELL | 2 | 67% | 1% | 2 | Search A+NK+CELL | Search A+NK+CELL |
5 | COMBINED IMMUNOCHEMOTHERAPY | 2 | 67% | 1% | 2 | Search COMBINED+IMMUNOCHEMOTHERAPY | Search COMBINED+IMMUNOCHEMOTHERAPY |
6 | LOCOREGIONAL IMMUNO CHEMOTHERAPY | 2 | 67% | 1% | 2 | Search LOCOREGIONAL+IMMUNO+CHEMOTHERAPY | Search LOCOREGIONAL+IMMUNO+CHEMOTHERAPY |
7 | LIVER ASSOCIATED LYMPHOCYTES | 1 | 38% | 1% | 3 | Search LIVER+ASSOCIATED+LYMPHOCYTES | Search LIVER+ASSOCIATED+LYMPHOCYTES |
8 | SECONDARY LIVER TUMORS | 1 | 50% | 1% | 2 | Search SECONDARY+LIVER+TUMORS | Search SECONDARY+LIVER+TUMORS |
9 | T LAK CELLS | 1 | 100% | 1% | 2 | Search T+LAK+CELLS | Search T+LAK+CELLS |
10 | TISSUE ISOLATED TUMORS | 1 | 100% | 1% | 2 | Search TISSUE+ISOLATED+TUMORS | Search TISSUE+ISOLATED+TUMORS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ADOPTIVELY TRANSFERRED ADHERENT | 25 | 63% | 8% | 25 |
2 | PIT CELLS | 8 | 31% | 7% | 22 |
3 | TRANSFERRED ADHERENT | 7 | 67% | 2% | 6 |
4 | MURINE METASTASES | 6 | 100% | 1% | 4 |
5 | RAT LIVER SINUSOIDS | 3 | 45% | 2% | 5 |
6 | RESPONSE MODIFIERS | 2 | 23% | 2% | 6 |
7 | A LAK CELLS | 1 | 50% | 1% | 2 |
8 | A NK | 1 | 100% | 1% | 2 |
9 | CELLS NPLC | 1 | 100% | 1% | 2 |
10 | IN VIVO IMMUNOSTIMULATION | 1 | 100% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity | 2003 | 100 | 68 | 31% |
Natural killer cells and tumor therapy | 1998 | 99 | 72 | 24% |
THE ROLE OF NATURAL-KILLER-CELLS IN IMMUNE SURVEILLANCE OF CANCER | 1995 | 195 | 47 | 21% |
On the function of pit cells, the liver-specific natural killer cells | 1997 | 28 | 122 | 32% |
Locoregional immuno(bio)therapy for liver metastases | 2002 | 18 | 30 | 33% |
Lymphocyte and macrophage populations in the liver | 1996 | 23 | 22 | 41% |
A novel drug delivery system using IL-2 activated NK cells and Zyn-linked doxorubicin | 2000 | 2 | 6 | 67% |
Role of NK cells in adoptive immunotherapy of metastatic colorectal cancer in a syngeneic rat model | 2001 | 13 | 75 | 27% |
Locoregional immunochemotherapy in primary and metastatic liver-disease: Meta-analysis and review of literature | 2003 | 0 | 34 | 53% |
Regulation and antimetastatic functions of liver-associated natural killer cells | 2000 | 43 | 70 | 14% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FUJI PLANT | 1 | 50% | 0.3% | 1 |
2 | GENE TRANSCRIPT UNIT | 1 | 50% | 0.3% | 1 |
3 | INTERDEPARTMENTAL CANC GIORGIO PRODI | 1 | 50% | 0.3% | 1 |
4 | BIOL PONSE MODIFIERS PROGRAMME | 0 | 33% | 0.3% | 1 |
5 | EXPT SURG ANAESTHESIA | 0 | 33% | 0.3% | 1 |
6 | INTERVENT RADIOL OPERAT UNIT | 0 | 33% | 0.3% | 1 |
7 | NEUROLESI | 0 | 20% | 0.3% | 1 |
8 | IMMUNOPATHOL EXPT PATHOL | 0 | 17% | 0.3% | 1 |
9 | MED CANC PATHOL | 0 | 11% | 0.3% | 1 |
10 | ABT HAMATOL | 0 | 10% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000171481 | EXTRATHYMIC T CELLS//EXTRATHYMIC T CELL//INTERMEDIATE TCR CELL |
2 | 0.0000169455 | SINUSOIDAL ENDOTHELIAL FENESTRAE//LIVER SIEVE//PSEUDOCAPILLARIZATION |
3 | 0.0000159409 | INTERLEUKIN 2//LYMPHOKINE ACTIVATED KILLER CELLS//RECOMBINANT INTERLEUKIN 2 |
4 | 0.0000148877 | MHC AF//IMMUNODIAG//CARBOHYDRATE COMPONENT |
5 | 0.0000084287 | TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//AUTOLYMPHOCYTE THERAPY |
6 | 0.0000077689 | OK 432//OK432//PROD LIFECYCLE MED INFORMAT |
7 | 0.0000071271 | DIFERENTIATION//HUMAN PANCREATIC CARCINOMA CELL LINES//LIVER SPECIFIC ANTIGEN |
8 | 0.0000068668 | ECCELLENZA RIC BIOMED//NKG2C//NK CELL MATURATION |
9 | 0.0000067545 | GRANZYME B//GRANZYME//PERFORIN |
10 | 0.0000066530 | MHC NONRESTRICTED CYTOTOXICITY//HISTAMINE DIHYDROCHLORIDE//BOWYER ONCOL |